Novavax CZ a.s. operates as a research and development and manufacturing-related entity within Novavax, a global biotechnology company focused on vaccines. The Czech operations are associated with development support, testing, manufacturing and quality activities related to recombinant protein-based vaccines and adjuvant technologies. Operations are integrated into Novavax's global R&D and production network. Geographic scope is international through group-level programs. Key assets include biotechnology expertise, regulated laboratory and production environments and integration into global vaccine development pipelines. Strategic focus emphasizes innovation in vaccine technologies, quality assurance and support of global public health initiatives.
Headquarters
Libalova 2348/1
Prague; The City of Prague;
Postal Code: 14900
Contact Details: Purchase the Novavax Cz A.S. report to view the information.
Website: https://www.novavax.com/
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS service
To view more information, Request a demonstration of the EMIS service